Dr. Robinson’s research deals primarily with the production of human monoclonal antibodies (MAbs) against viral glycoproteins. Dr. Robinson has many years of experience in generating human and monkey MAbs that recognize HIV-1, HIV-2, and SIV surface glycoproteins. He was the first to explore the identification of conserved and variant epitopes of HIV-1 SU (gp120) using human MAb produced by EBV-transformed cell lines. He is currently a collaborating investigator in the NIH Center for HIV/AIDS Vaccine Immunology (CHAVI) headed by Barton Haynes at Duke University and his is a collaborating investigator in four large consortia projects funded by the Bill and Melinda Gates Foundation.
